trial
as of 2026-07-01Pregablin for Anxiety-comorbidity in Patients With Schizophrenia
NCTId NCT01496690
at a glance
Phase 4 · Completed
Enrollment 54 (actual)
Sponsored by University of Aarhus
Primary completion 2016-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
54 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2012-01
Primary completion
2016-12
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of AarhusLead Sponsor
Albert Einstein College of MedicineCollaborator
Investigators
1
Ole Schjerning, M.D.Principal Investigator
Sites
1 total
Aalborg, Denmark
Facts & assertions
4 sourced
Enrollment
54
Phase
PHASE4
Primary Completion Date
2016-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
indication
investigator
person